Search clinical trials for: Part A: TRV250-20mg/ml
Total 602 results
-
Trevena Inc.TerminatedMigrainesUnited Kingdom
-
Dompé Farmaceutici S.p.ACovanceCompletedHealthySwitzerland, United Kingdom
-
Chong Kun Dang PharmaceuticalCompletedType2 Diabetes MellitusKorea, Republic of
-
Sharon WalshNational Institute on Drug Abuse (NIDA); Merck Sharp & Dohme LLCCompleted
-
GlaxoSmithKlineTerminatedMultiple Sclerosis, Relapsing-RemittingUnited Kingdom
-
AstraZenecaCompletedCardiovascular Disease | Healthy Male SubjectsUnited Kingdom
-
Cambridge University Hospitals NHS Foundation TrustUniversity of CambridgeActive, not recruitingCardiovascular Diseases | AtherosclerosisUnited Kingdom
-
AstraZenecaParexelRecruiting
-
Verona Pharma plcIqvia Pty LtdCompleted
-
Eli Lilly and CompanyCompleted
-
AstraZenecaCompletedGonococcal (GC) InfectionUnited States
-
Huahui HealthCompleted
-
GLWL Research Inc.TerminatedDiabetes Mellitus, Type 2United States
-
Eisai Co., Ltd.Completed
-
Kadmon Corporation, LLCQuotient SciencesCompletedHealthy VolunteersUnited Kingdom
-
Global Alliance for TB Drug DevelopmentCompletedTuberculosis | Tuberculosis, Pulmonary | Pulmonary Disease | Multi Drug Resistant Tuberculosis | Drug Sensitive Tuberculosis | Drug-resistant Tuberculosis | Mycobacterium Tuberculosis InfectionUnited States
-
Verona Pharma plcIqvia Pty LtdCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
Emory UniversityTerminatedSickle Cell DiseaseUnited States
-
Mereo BioPharmaNovartisTerminatedAcute Kidney InjuryTaiwan, United States, Israel
-
Asan Medical CenterNot yet recruitingGynecologic CancerKorea, Republic of
-
Protgen LtdUnknownAdvanced Solid TumorsChina
-
Kowa Company, Ltd.Completed
-
Ferring PharmaceuticalsRecruitingInflammatory Gastrointestinal DiseasesGermany
-
MBX BiosciencesCompleted
-
Vertex Pharmaceuticals IncorporatedTerminatedEpilepsyUnited States, Germany
-
Hospital Sant Joan de DeuFundació Sant Joan de Déu; Spanish National Health SystemCompletedPediatric High Risk GliomasSpain
-
Kanyos Bio, Inc., a wholly-owned subsidiary of...PfizerRecruitingCeliac DiseaseUnited States, Australia, New Zealand
-
RedHill Biopharma LimitedSuspendedCovid19United States, South Africa
-
Mineralys Therapeutics Inc.Recruiting
-
Aesculap AGCompletedAdhesions | Abdominal CavityGermany
-
AceLink Therapeutics, Inc.Novotech (Australia) Pty LimitedCompletedAutosomal Dominant Polycystic KidneyAustralia
-
Cara Therapeutics, Inc.CompletedPruritus | Uremic PruritusUnited States
-
Beijing Biostar Pharmaceuticals Co., Ltd.RecruitingAdvanced Solid TumorChina
-
Novartis PharmaceuticalsActive, not recruitingSickle Cell DiseaseUnited States
-
AstraZenecaCompletedHealthy Volunteers | Tolerability | SafetyUnited Kingdom
-
AstraZenecaAcerta Pharma, LLCCompletedBioavailability | B-cell Lymphoid CancerUnited States
-
Rutgers, The State University of New JerseyCompleted
-
OliPass CorporationCompleted
-
Melbourne HealthAnHeart Therapeutics Inc.; Walter and Eliza Hall Institute of Medical ResearchActive, not recruiting
-
GlaxoSmithKlineCompletedArthritis, Rheumatoid
-
Stealth BioTherapeutics Inc.CompletedFuchs' Corneal Endothelial Dystrophy (FCED)United States
-
The Royal Wolverhampton Hospitals NHS TrustCompleted
-
Bukwang PharmaceuticalActive, not recruitingParkinson Disease | DyskinesiasUnited States
-
PfizerCompletedRheumatoid Arthritis | Healthy VolunteersUnited States
-
Société des Produits Nestlé (SPN)CompletedExocrine Pancreatic InsufficiencyAustralia, New Zealand